Literature DB >> 17464970

Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study.

Geoffrey C Nguyen1, Dorry L Segev, Paul J Thuluvath.   

Abstract

UNLABELLED: Having complications of portal hypertension is a harbinger of decompensated cirrhosis and warrants consideration for liver transplantation (LT). Racial disparities in LT have been reported. We sought to characterize disparities in the performing of surgical and endoscopic procedures among hospitalized patients with complications of portal hypertension. We queried the Nationwide Inpatient Sample from 1998 to 2003 to identify patients with cirrhosis and complications of portal hypertension. Logistic regression controlling for confounders was used to evaluate race as a predictor of undergoing a portosystemic shunt and LT and of dying in the hospital. Compared to whites, the adjusted odds ratios of receiving a portosystemic shunt were 0.37 (95% CI: 0.27-0.51) and 0.69 (95% CI: 0.54-0.88) for African Americans (AAs) and Hispanics, respectively. AAs with variceal bleeding were more likely to have endoscopic variceal hemostasis delayed more than 24 hours after admission than were whites (OR 1.6; 95% CI: 1.2-2.1). The adjusted odds ratios of undergoing LT were 0.32 (95% CI:0.20-0.52) and 0.46 (95% CI: 0.25-0.83) for AAs and Hispanics, respectively. Compared to whites, AAs experienced higher in-hospital mortality (OR 1.12; 95% CI: 1.01-1.24), whereas Hispanics had a lower risk of death (OR 0.83; 95% CI: 0.75-0.92). Among variceal bleeders, the odds ratio of death for AAs was 1.7 (95% CI: 1.2-2.4) compared to whites.
CONCLUSION: AAs and Hispanics hospitalized for complications of portal hypertension were less likely to undergo a palliative shunt or LT than whites, which may contribute to the higher in-hospital mortality of AAs. Further studies are warranted to elucidate the mechanisms of these exploratory findings.

Entities:  

Mesh:

Year:  2007        PMID: 17464970     DOI: 10.1002/hep.21580

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  32 in total

1.  Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian
Journal:  Dig Dis Sci       Date:  2011-01-30       Impact factor: 3.199

Review 2.  Advances in the current treatment of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

3.  Ethnic disparities in liver transplantation.

Authors:  Nyingi Kemmer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

4.  Racial differences in hepatitis C treatment eligibility.

Authors:  Michael T Melia; Andrew J Muir; Jonathan McCone; Mitchell L Shiffman; John W King; Steven K Herrine; Greg W Galler; Joseph R Bloomer; Frederick A Nunes; Kimberly A Brown; Kevin D Mullen; Natarajan Ravendhran; Reem H Ghalib; Navdeep Boparai; Ruiyun Jiang; Stephanie Noviello; Clifford A Brass; Janice K Albrecht; John G McHutchison; Mark S Sulkowski
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

5.  Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.

Authors:  Kendall R Beck; Nicole Kim; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2016-10-14       Impact factor: 3.199

6.  Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates.

Authors:  Margaux N Mustian; Brittany A Shelton; Paul A MacLennan; Rhiannon D Reed; Jared A White; Devin E Eckhoff; Jayme E Locke; Richard M Allman; Stephen H Gray
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 7.  Venous thromboembolism in cirrhosis.

Authors:  Zhineng J Yang; Karen A Costa; Enrico M Novelli; Roy E Smith
Journal:  Clin Appl Thromb Hemost       Date:  2012-10-17       Impact factor: 2.389

8.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Authors:  J S Bajaj; S M Ratliff; D M Heuman; K L Lapane
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

9.  The Effect of Hospital Characteristics on Racial/Ethnic Variation in Cirrhosis Mortality.

Authors:  Apurba Chakrabarti; Nicholas H Osborne; Amol S Rangnekar; Amit K Mathur
Journal:  J Racial Ethn Health Disparities       Date:  2016-04-11

Review 10.  Liver transplantation in the ethnic minority population: challenges and prospects.

Authors:  Nyingi Kemmer; Guy W Neff
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.